Skip to main content
. 2019 Jul 9;9:9945. doi: 10.1038/s41598-019-45865-x

Table 5.

Postoperative data of surgery groups.

Treatment group RT FT FT + ISBS P α P β P γ
Hb, g/L 9.3 ± 0.7 9.4 ± 0.9 11.2 ± 1.1 NS <0.05† <0.05§
TBil, μmol/L 37.5 ± 5.6 39.2 ± 7.1 38.2 ± 6.5 NS NS NS
IBil, μmol/L 27.8 ± 5.1 29.8 ± 6.7 29.6 ± 7.7 NS NS NS
AST, U/L 255.2 ± 99.2 249.2 ± 86.1 220.1 ± 80.8 NS NS NS
ALT, U/L 452.1 ± 175.3 488.7 ± 251.4 430.6 ± 186.5 NS NS NS
Hb increase (1d), g/L 0.5 ± 0.2 0.6 ± 0.4 2.3 ± 1.0 NS <0.05† <0.05§
Hb increase (3d) 0.6 ± 0.3 0.5 ± 0.2 2.5 ± 0.8 NS <0.05† <0.05§
Hospital stay, d 8.4 ± 2.2 6.7 ± 2.8 5.4 ± 1.3 <0.05* <0.05† <0.05§
Hospitalization expenses, RMB (thousand) 66.5 ± 21.5 53.5 ± 16.8 41.2 ± 13.6 <0.05* <0.05† <0.05§

Haemoglobin = Hb; Hb increase = Hb (postoperaion) - Hb (preoperation); F = female; M = male; TBil = Total bilirubin; IBil = Indirect bilirubin; AST = glutamic oxalacetic transaminase; ALT = glutamic-pyruvic transaminase; NS = not significant.

Pα FT group comparring to RT group, <0.05 has statistical significance*;

PβFT + ISBS group comparring to RT group, <0.05 has statistical significance†;

PγFT + ISBS group comparring to FT group, <0.05 has statistical significance§.